1. |
Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case-control study in North Indian population. |
Askari M, etal., Mol Biol Rep. 2013 Aug;40(8):4921-8. doi: 10.1007/s11033-013-2592-5. Epub 2013 May 28.
|
2. |
Ocular expression and distribution of products of the POAG-associated chromosome 9p21 gene region. |
Chidlow G, etal., PLoS One. 2013 Sep 19;8(9):e75067. doi: 10.1371/journal.pone.0075067. eCollection 2013.
|
3. |
Expression of the cell cycle regulators p14(ARF) and p16(INK4a) in chronic myeloid leukemia. |
Cividin M, etal., Leuk Res. 2006 Oct;30(10):1273-8. Epub 2006 Mar 14.
|
4. |
Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. |
Debies MT, etal., J Clin Invest. 2008 Jan;118(1):51-63.
|
5. |
Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells. |
Diaz-Rodriguez E, etal., Oncogene. 2012 Jun 7;31(23):2824-35. doi: 10.1038/onc.2011.458. Epub 2011 Oct 24.
|
6. |
Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia. |
Hauer J, etal., Blood. 2011 Jul 21;118(3):544-53. doi: 10.1182/blood-2010-09-305383. Epub 2011 May 26.
|
7. |
Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. |
Heidenreich A, etal., J Urol. 1998 May;159(5):1725-30.
|
8. |
Homozygous deletions of the INK4a/ARF locus in renal cell cancer. |
Kasahara T, etal., Anticancer Res. 2006 Nov-Dec;26(6B):4299-305.
|
9. |
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer. |
Kawamoto K, etal., Biochem Biophys Res Commun. 2006 Jan 20;339(3):790-6. Epub 2005 Nov 22.
|
10. |
Ink4a/Arf expression is a biomarker of aging. |
Krishnamurthy J, etal., J Clin Invest 2004 Nov;114(9):1299-307.
|
11. |
Alterations of P19ARF in rodent hepatoma cell lines but not in human primary liver cancer. |
Laes J, etal., Cancer Genet Cytogenet 2000 Mar;117(2):118-24.
|
12. |
A novel p16INK4A transcript. |
Mao L, etal., Cancer Res. 1995 Jul 15;55(14):2995-7.
|
13. |
Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells. |
Mariappan MM, etal., Am J Physiol Renal Physiol. 2011 Jan;300(1):F219-30. doi: 10.1152/ajprenal.00207.2010. Epub 2010 Oct 13.
|
14. |
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. |
Quelle DE, etal., Cell 1995 Dec 15;83(6):993-1000.
|
15. |
The INK4a /ARF locus: role in cell cycle control for renal cell epithelial tumor growth after the Chernobyl accident. |
Romanenko A, etal., Virchows Arch. 2004 Sep;445(3):298-304. Epub 2004 Jul 1.
|
16. |
p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice. |
Shank-Calvo JA, etal., Oncogene. 2006 May 18;25(21):3023-31.
|
17. |
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. |
Sharma G, etal., Life Sci. 2007 Apr 24;80(20):1873-81. Epub 2007 Feb 27.
|
18. |
Complex structure and regulation of the P16 (MTS1) locus. |
Stone S, etal., Cancer Res 1995 Jul 15;55(14):2988-94.
|
19. |
Role of the E2F1-p19-p53 pathway in ischemic acute renal failure. |
Tanaka H, etal., Nephron Physiol 2005;101(2):p27-34. Epub 2005 Jun 30.
|
20. |
Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes. |
Tschan MP, etal., Leuk Lymphoma. 2001 Sep-Oct;42(5):1077-87.
|
21. |
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia. |
Volanakis EJ, etal., Blood. 2009 Nov 12;114(20):4451-9. doi: 10.1182/blood-2009-07-233346. Epub 2009 Sep 16.
|
22. |
Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia. |
Williams RT, etal., Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6688-93. Epub 2006 Apr 17.
|
23. |
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. |
Zhang Z, etal., Mod Pathol. 2006 Oct;19(10):1339-43. Epub 2006 Jun 23.
|